AstraZeneca

MedImmune's top cancer researcher jumps ship to small biotech
Fierce Biotech
Wed, 10/16/19 - 12:26 pm
R&D
MedImmune
AstraZeneca
Pyxis Oncology
AZ got past FluMist's efficacy woes, but now it's plagued by production problems
Fierce Pharma
Mon, 10/14/19 - 11:58 pm
AstraZeneca
FluMist
ImaginAb joins with AZ, Pfizer and Takeda to develop tumour imaging tech
Pharmaforum
Mon, 10/14/19 - 09:50 am
ImaginAb
tumor imaging
AstraZeneca
Pfizer
Takeda
Big Pharma giving more money to patient advocacy groups
Beckers Hospital Review
Wed, 10/9/19 - 11:15 pm
Big Pharma
JNJ
AbbVie
Bristol-Myers Squibb
Pfizer
Merck
AstraZeneca
patient advocacy groups
Lilly touts Cyramza lung cancer data, as AZ’s Tagrisso grows even more powerful
Fierce Pharma
Mon, 10/7/19 - 12:18 pm
EGFR lung cancer
lung cancer
Eli Lilly
Cyramza
AstraZeneca
Tagrisso
FDA green lights AstraZeneca's asthma drug Fasenra for self-administration
Yahoo/Reuters
Fri, 10/4/19 - 10:25 am
AstraZeneca
FDA
asthma
Fasenra
As its oncology effort gathers steam, AstraZeneca sheds another legacy drug
Endpoints
Wed, 10/2/19 - 10:48 am
AstraZeneca
Losec
AstraZeneca's combo lung disease therapy fails to win FDA approval
Reuters
Tue, 10/1/19 - 10:35 am
AstraZeneca
FDA
COPD
PT010
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
Xconomy
Tue, 10/1/19 - 10:29 am
ESMO
PARP inhibitors
prostate cancer
KRAS
Seattle Genetics
AstraZeneca
Merck
GSK
Amgen
breast cancer
Roche
Pfizer
ESMO: AstraZeneca eyes payer boost with Tagrisso's latest survival win
Fierce Pharma
Sun, 09/29/19 - 09:29 pm
AstraZeneca
Tagrisso
EGFR lung cancer
ESMO
Separate GSK, AstraZeneca trial results may widen ovarian cancer drug use
Yahoo/Reuters
Sun, 09/29/19 - 11:57 am
GSK
AstraZeneca
ESMO
ovarianc cancer
PARP inhibitors
Lynparza
Zejula
AstraZeneca strengthens lead in PARP drug class
Biopharma Dive
Sat, 09/28/19 - 05:00 pm
AstraZeneca
Merck
Lynparza
ovarian cancer
PARP inhibitors
veliparib
ESMO: AZ, Merck's Lynparza chases Avastin combo nod with big ovarian cancer win
Fierce Pharma
Sat, 09/28/19 - 04:49 pm
Roche
Avastin
ovarian cancer
AstraZeneca
Merck
Lynparza
ESMO
GSK and AstraZeneca's PARP Inhibitors Will Flex Their Muscles at ESMO
BioSpace
Thu, 09/26/19 - 12:33 pm
GSK
AstraZeneca
PARP inhibitors
ESMO
Lynparza
Zejula
Sanofi, AZ, Lilly and more win business in China's expanded cut-price purchase program
Fierce Pharma
Wed, 09/25/19 - 11:30 pm
China
Sanofi
AstraZeneca
Eli Lilly
drug pricing
Deepening US footprint, AstraZeneca-partnered French biotech Innate shoots for $100M IPO
Endpoints
Mon, 09/23/19 - 10:49 am
Innate Pharma
IPOs
AstraZeneca
blood cancer
solid tumors
The Week Ahead In Biotech: Spotlight On ESMO Conference
Yahoo/Benzinga
Sun, 09/22/19 - 11:10 pm
JNJ
daratumumab
Urogen
Rhythm Pharmaceuticals
Anavex
Aravive Biologics
TrovaGene
Incyte
AstraZeneca
Roche
Amgen
Aslan
G1 Therapeutics
GSK
Calithera Biosciences
Seattle Genetics
Immunomedics
Checkpoint Therapeutics
Aileron Therapeutics
Genocea Biosciences
AbbVie
Zymeworks
EASD: AstraZeneca piles on supporting evidence for Farxiga use in heart failure
Fierce Pharma
Thu, 09/19/19 - 07:59 pm
AstraZeneca
Farxiga
EASD
heart failure
AstraZeneca diabetes drug granted fast track status for heart failure treatment
Yahoo/Reuters
Mon, 09/16/19 - 09:28 am
AstraZeneca
Farxiga
heart failure
diabetes
FDA
fast track
Real world evidence, digital partnerships and the future of pharma
Pharmaforum
Fri, 09/13/19 - 10:51 am
digital pharma
AstraZeneca
RWE
real world evidence

Pages